Venture Capital Perspective: Medical Devices & Digital Health, Lee Wrubel, Foundation Medical Partners
0 Views0 Comments0 Likes
During this event, Dr. Lee Wrubel of Foundation Medical Partners, discusses venture capital perspectives on the evolution of the start-up landscape in medical devices and digital health. Lee also shared his views on building a career in venture capital, tips for pitching investors for early-stage technology companies, and ways for aspiring entrepreneurs to make the most of their time at Columbia. This event was co-sponsored by the Columbia Business School Eugene Lang Entrepreneurship Center, the Center for Advanced Information Management, and Health Tech Assembly. Foundation Medical Partners has been an early, active venture investor in many companies that subsequently went public or were acquired in strategic transactions, such as CardioMEMS (St Jude Medical) AtriCure (NASDAQ: ATRC), CardioNet (NASDAQ: BEAT), CombinatoRx (NASDAQ: ZLCS), Immunicon (NASDAQ: IMMC, later acquired by Johnson & Johnson), Northstar Neuroscience (NASDAQ: NSTR, later acquired by St. Jude Medical), and Visiogen (acquired by Abbott). They actively manage over $350 million in venture capital, with a market capitalization of healthcare investments totaling over $2 billion. The firm is currently investing from a new $150M+ fund focused on early stage digital health companies. About the Speakers: Lee Wrubel, MD, General Partner, Foundation Medical Partners, brings more than two decades of venture capital experience to his role at Foundation Medical Partners and has a passion for healthcare information and medical technology companies. Prior to co-founding FMP in 2001, Lee served as an investment professional with Highland Capital Partners and Canaan Partners where he worked closely with the management of a large number of private companies. He began his business career as a consultant at The Wilkerson Group, a healthcare-focused management consulting company. Lee currently serves on the Commercial Advisory Board of the Global Cardiovascular Innovation Center at the Cleveland Clinic. He is also a founder of the Coalition to Cure Calpain 3, a non-profit research organization founded to fund research into a rare form of muscular dystrophy. Lee earned an M.D. and Masters in Public Health from Tufts University, and an M.B.A. from Columbia University. Lee also completed a pediatric internship at Mount Sinai Medical Center in New York. Orin Herskowitz, VP of Intellectual Property and Tech Transfer for Columbia University and Executive Director of Columbia Technology Ventures (CTV), is also an Adjunct Professor at Columbia’s Business and Engineering Schools. He has been a Board Member or Advisor to a number of innovation and entrepreneurship-focused initiatives in NYC, including the NYC Media Lab, NYC ACRE, the Coulter Translational Partnership, PowerBridgeNY, and HarlemBiospace. Orin received his BA from Yale and his MBA from the Wharton School of Business. Prior to joining Columbia in 2006, Orin spent 7 years at the Boston Consulting Group's New York office as a strategy consultant, and was previously an entrepreneur and a consultant to start-ups.